Sensitive bioluminescence imaging of cryptococcosis in Galleria mellonella improves antifungal screening under in vivo conditions

References

• Denham ST, Brown JCS. Mechanisms of pulmonary escape and dissemination by Cryptococcus neoformans. J Fungi Basel Switz. 2018 Feb 17;4(1):25. doi: 10.3390/jof4010025
   Google Scholar
• Rajasingham R, Govender NP, Jordan A, et al. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis. 2022 Dec;22(12):1748–10. doi: 10.1016/S1473-3099(22)00499-6
   PubMed Web of Science ®Google Scholar
• de SC, Wirth C, F LL, et al. New approaches for cryptococcosis treatment. Microorganisms. 2020 Apr 23;8(4):613. doi: 10.3390/microorganisms8040613
   PubMed Web of Science ®Google Scholar
• Stone NRH, Rhodes J, Fisher MC, et al. Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis. J Clin Invest. 2019 Jan 28;129(3):999–1014. doi: 10.1172/JCI124516
   PubMed Web of Science ®Google Scholar
• Bongomin F, Oladele RO, Gago S, et al. A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species. Mycoses. 2018 May;61(5):290–297. doi: 10.1111/myc.12747
   PubMed Web of Science ®Google Scholar
• Stott KE, Loyse A, Jarvis JN, et al. Cryptococcal meningoencephalitis: time for action. Lancet Infect Dis. 2021 Sep;21(9):e259–71. doi: https://doi.org/10.1016/S1473-3099(20)30771-4
   PubMed Web of Science ®Google Scholar
• WHO. Fungal priority pathogens list to guide research, development and public health action. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
   Google Scholar
• De Jesus DFF, De Freitas ALD, De Oliveira IM, et al. Organoselenium has a potent fungicidal effect on Cryptococcus neoformans and inhibits the virulence factors. Antimicrob Agents Chemother. 2023 Feb 23.
   Google Scholar
• Xin C, Wang F, Zhang J, et al. Secretions from Serratia marcescens inhibit the growth and biofilm formation of Candida spp. And Cryptococcus neoformans. J Microbiol. 2023 Feb;61(2):221–232. doi: 10.1007/s12275-023-00037-5
   PubMed Web of Science ®Google Scholar
• Wang T, Pan M, Xiao N, et al. In vitro and in vivo analysis of monotherapy and dual therapy with ethyl caffeate and fluconazole on virulence factors of Candida albicans and systemic candidiasis. J Glob Antimicrob Resist. 2021 Dec;27:253–266. doi: 10.1016/j.jgar.2021.10.005
   PubMed Web of Science ®Google Scholar
• Andriani GM, Morguette AEB, Spoladori LFA, et al. Antifungal Combination of Ethyl Acetate Extract of Poincianella pluviosa (DC.) L. P. Queiros Stem Bark With Amphotericin B in Cryptococcus neoformans. Front Microbiol. 2021 Jun 10;12:660645. doi: 10.3389/fmicb.2021.660645
   PubMed Web of Science ®Google Scholar
• Jemel S, Guillot J, Kallel K, et al. Galleria mellonella for the Evaluation of Antifungal Efficacy against Medically Important Fungi, a Narrative Review. Microorganisms. 2020 Mar 11;8(3):390. doi: 10.3390/microorganisms8030390
   PubMed Web of Science ®Google Scholar
• Kong Q, Cao Z, Lv N, et al. Minocycline and Fluconazole Have a Synergistic Effect Against Cryptococcus neoformans Both in vitro and in vivo. Front Microbiol. 2020 May 5;11:836. doi: 10.3389/fmicb.2020.00836
   PubMed Web of Science ®Google Scholar
• Eisemann CH, Jorgensen WK, Merritt DJ, et al. Do insects feel pain? — a biological view. Experientia. 1984 Feb;40(2):164–167. doi: 10.3390/jof4010025
   Google Scholar
• Ménard G, Rouillon A, Cattoir V, et al. Galleria mellonella as a Suitable Model of Bacterial Infection: Past, Present and Future. Front Cell Infect Microbiol. 2021;11:782733. doi: 10.3389/fcimb.2021.782733
   PubMed Web of Science ®Google Scholar
• Tsai CJY, Loh JMS, Proft T. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence. 2016 Apr 2;7(3):214–229. doi: 10.1080/21505594.2015.1135289
   PubMed Web of Science ®Google Scholar
• Serrano I, Verdial C, Tavares L, et al. The virtuous galleria mellonella model for scientific experimentation. Antibiotics. 2023 Mar 3;12(3):505. doi: 10.3390/antibiotics12030505
   Google Scholar
• Curtis A, Binder U, Kavanagh K. Galleria mellonella Larvae as a Model for Investigating Fungal—Host Interactions. Front Fungal Biol. 2022 Apr 26;3:893494. doi: 10.3389/ffunb.2022.893494
   PubMedGoogle Scholar
• Slater JL, Gregson L, Denning DW, et al. Pathogenicity of aspergillus fumigatus mutants assessed in galleria mellonella matches that in mice. Med Mycol. 2011 Apr;49(S1):S107–13. doi: 10.3109/13693786.2010.523852
   PubMedGoogle Scholar
• Brennan M, Thomas DY, Whiteway M, et al. Correlation between virulence of Candida albicans mutants in mice and galleria mellonella larvae. FEMS Immunol Med Microbiol. 2002 Oct;34(2):153–157. doi: 10.1111/j.1574-695X.2002.tb00617.x
   PubMedGoogle Scholar
• Jander G, Rahme LG, Ausubel FM. Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects. J Bacteriol. 2000 Jul;182(13):3843–3845. doi: 10.1128/JB.182.13.3843-3845.2000
   PubMed Web of Science ®Google Scholar
• Olsen RJ, Watkins ME, Cantu CC, et al. Virulence of serotype M3 group a streptococcus strains in wax worms (galleria mellonella larvae). Virulence. 2011 Mar;2(2):111–119. doi: 10.4161/viru.2.2.14338
   PubMed Web of Science ®Google Scholar
• Ignasiak K, Maxwell A. Galleria mellonella (greater wax moth) larvae as a model for antibiotic susceptibility testing and acute toxicity trials. BMC Res Notes. 2017 Aug 29;10(1):428. doi: 10.1186/s13104-017-2757-8
   PubMedGoogle Scholar
• Thammasit P, Tharinjaroen CS, Tragoolpua Y, et al. Targeted propolis-loaded poly (butyl) cyanoacrylate nanoparticles: an alternative drug delivery tool for the treatment of cryptococcal meningitis. Front Pharmacol. 2021 Aug 20;12:723727. doi: 10.3389/fphar.2021.723727
   PubMed Web of Science ®Google Scholar
• Loh JMS, Adenwalla N, Wiles S, et al. Galleria mellonella larvae as an infection model for group A streptococcus. Virulence. 2013 Jul 1;4(5):419–428. doi: 10.4161/viru.24930
   PubMed Web of Science ®Google Scholar
• Resendiz-Sharpe A, Van Holm W, Merckx R, et al. Quantitative PCR Effectively Quantifies Triazole-Susceptible and Triazole-Resistant Aspergillus fumigatus in Mixed Infections. J Fungi. 2022 Oct 25;8(11):1120. doi: 10.3390/jof8111120
   Web of Science ®Google Scholar
• Vanhoffelen E, Michiels L, Brock M, et al. Powerful and Real-Time Quantification of Antifungal Efficacy against Triazole-Resistant and -Susceptible Aspergillus fumigatus Infections in Galleria mellonella by Longitudinal Bioluminescence Imaging. Microbiol spectr. 2023 Aug 17;11(4):e0082523. doi: 10.1128/spectrum.00825-23
   PubMed Web of Science ®Google Scholar
• Vanherp L, Ristani A, Poelmans J, et al. Sensitive bioluminescence imaging of fungal dissemination to the brain in mouse models of cryptococcosis. Dis Model Mech. 2019 Jun 1;12(6):dmm039123. doi: 10.1242/dmm.039123
   PubMed Web of Science ®Google Scholar
• Papon N, Courdavault V, Lanoue A, et al. Illuminating fungal infections with bioluminescence. PLoS Pathog. 2014 Jul;10(7):e1004179. doi: 10.1371/journal.ppat.1004179
   PubMed Web of Science ®Google Scholar
• Cruz-Leite VR M, Tomazett MV, de Curcio J S, et al. Bioluminescence imaging in Paracoccidioides spp.: A tool to monitor the infectious processes. Microbes Infect. 2022 Apr;24(6–7):104975. doi: 10.1016/j.micinf.2022.104975s
   PubMed Web of Science ®Google Scholar
• Seldeslachts L, Vanderbeke L, Fremau A, et al. Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model. Virulence. 2021 Dec 31;12(1):2493–2508. doi: 10.1080/21505594.2021.1974327
   PubMed Web of Science ®Google Scholar
• Reséndiz Sharpe A, da Silva RP, Geib E, et al. Longitudinal multimodal imaging-compatible mouse model of triazole sensitive and resistant invasive pulmonary aspergillosis. Dis Model Mech. 2022;15(3). doi: 10.1242/dmm.049165
   PubMed Web of Science ®Google Scholar
• Binder U, Navarro-Mendoza MI, Naschberger V, et al. Generation of a Mucor circinelloides reporter strain-A promising new tool to study antifungal drug efficacy and Mucormycosis. Genes (Basel). 2018 Dec 7;9(12):613. doi: 10.3390/genes9120613
   PubMed Web of Science ®Google Scholar
• Jacobsen ID, Lüttich A, Kurzai O, et al. In vivo imaging of disseminated murine Candida albicans infection reveals unexpected host sites of fungal persistence during antifungal therapy. J Antimicrob Chemother. 2014 Oct;69(10):2785–2796. doi: 10.1093/jac/dku198
   PubMed Web of Science ®Google Scholar
• Delarze E, Ischer F, Sanglard D, et al. Adaptation of a gaussia princeps luciferase reporter system in candida albicans for in vivo detection in the galleria mellonella infection model. Virulence. 2015;6(7):684–693. doi: 10.1080/21505594.2015.1081330
   PubMed Web of Science ®Google Scholar
• Troy T, Jekic-McMullen D, Sambucetti L, et al. Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. Mol Imaging. 2004 Jan;3(1):153535002004031. do i:
   Google Scholar
• Cohen-Wolkowiez M, Moran C, Benjamin DK, et al. Pediatric antifungal agents. Curr Opin Infect Dis. 2009 Dec;22(6):553–558. doi: 10.1097/QCO.0b013e3283321ccc
   PubMed Web of Science ®Google Scholar